← Leaderboards
Fred W Perrino
Wake Forest University Health Sciences
$7,071,434
Attributed
$7,071,434
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $783.5K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$7,071,434 · 4
By mechanism
R01$7,071,434 · 4
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Stephanie Coffin$73,269
Others in their field
Top investigators on “Trex1 Gene”
- William G. Dunphy · California Institute Of Technology$4,801,595
- David K Cortez · Vanderbilt University$4,690,613
- Judy Lieberman · Boston Children'S Hospital$4,641,898
- Daniel B Stetson · University Of Washington$4,099,217
- Alexander Poltorak · Tufts University Boston$3,732,014
- Nan Yan · Ut Southwestern Medical Center$3,482,080
Research focus
Trex1 GeneInsightBiochemicalComplexMutantEnzymesCellsMutationAutoimmune DiseasesExonucleaseStructureBiochemistryMolecularSeriesRoentgen RaysGenesNucleotidesLaboratoriesPathway InteractionsGeneticNucleic AcidsCell DeathApplications GrantsApoptotic
Grant awards (21)
The TREX1 Pathway in Autoimmune Disease$386,640
R01 · FY2020 · AI · contact PI
The TREX1 Pathway in Autoimmune Disease$386,640
R01 · FY2019 · AI · contact PI
The TREX1 Pathway in Autoimmune Disease$386,640
R01 · FY2018 · AI · contact PI
The TREX1 Pathway in Autoimmune Disease$386,640
R01 · FY2017 · AI · contact PI
Cellular Nucleotide Metabolism in HIV Restriction$383,140
R01 · FY2017 · GM · contact PI
The TREX1 Pathway in Autoimmune Disease$400,390
R01 · FY2016 · AI · contact PI
Cellular Nucleotide Metabolism in HIV Restriction$383,140
R01 · FY2016 · GM · contact PI
Cellular Nucleotide Metabolism in HIV Restriction$382,846
R01 · FY2015 · GM · contact PI
Cellular Nucleotide Metabolism in HIV Restriction$394,415
R01 · FY2014 · GM · contact PI
Mechanisms of the 3'-->5' deoxyribonucleases$356,658
R01 · FY2012 · GM · contact PI
Mechanisms of the 3'-->5' deoxyribonucleases$356,657
R01 · FY2011 · GM · contact PI
Mechanisms of the 3'-->5' deoxyribonucleases$360,363
R01 · FY2010 · GM · contact PI
Mechanisms of the 3'-->5' deoxyribonucleases$356,655
R01 · FY2009 · GM · contact PI
Mechanisms of the 3'-->5' deoxyribonucleases$353,499
R01 · FY2009 · GM · contact PI
Mechanisms of the 3'-5' deoxyribonucleases$272,128
R01 · FY2007 · GM · contact PI
Mechanisms of the 3'-5' deoxyribonucleases$280,256
R01 · FY2006 · GM · contact PI
Mechanisms of the 3'-5'deoxyribonucleases$287,000
R01 · FY2005 · GM
Mechanisms of the 3'-5'deoxyribonucleases$287,000
R01 · FY2004 · GM
EXONUCLEASE IN THERAPEUTIC RESISTANCE TO ANTITUMOR DRUGS$230,217
R01 · FY2002 · CA
EXONUCLEASE IN THERAPEUTIC RESISTANCE TO ANTITUMOR DRUGS$223,510
R01 · FY2001 · CA
EXONUCLEASE IN THERAPEUTIC RESISTANCE TO ANTITUMOR DRUGS$217,000
R01 · FY2000 · CA